Hubei Yihua Chemical Industry Co Ltd

Hubei Yihua Chemical Industry Co Ltd maintains a capital structure with a debt-to-equity ratio of 1.45, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.76, suggesting potential short-term liquidity constraints. Cash and equivalents amount to 865.25 million CNY, but this is significantly lower than the long-term debt of 10.44 billion CNY, resulting in a negative net cash position.

Profitability metrics show a return on equity (ROE) of 7.98% and a return on assets (ROA) of 2.46%, both below the typical thresholds for high-performing chemical firms. The gross profit margin is 25.6%, and the operating margin is 12.65%, which are in line with the industry median for Diversified Chemicals but suggest limited pricing power or cost control advantages.

The company's revenue is concentrated in a few key segments, with disclosed operations in fertilizers, pesticides, and chemical derivatives. Geographic exposure is primarily within China, with no material international revenue disclosed. This concentration increases vulnerability to domestic economic shifts and regulatory changes.

Growth trajectory appears modest, with no significant revenue acceleration in recent periods. The company's operating cash flow of 2.16 billion CNY supports operations but is insufficient to cover capital expenditures of 1.9 billion CNY, indicating reinvestment in core operations rather than expansion. Analysts project a neutral outlook, with a mean price target of 17.13 CNY and a median of 17.13 CNY.

Risk factors include liquidity constraints and a high debt load, with a debt-to-equity ratio of 1.45. The company has a low dilution risk, with no near-term pressure from share issuance. However, the negative net cash position and reliance on long-term debt could increase financial risk in a rising interest rate environment.

Recent filings and transcripts indicate no major strategic shifts or capital-raising events. The company continues to focus on cost optimization and operational efficiency, with no material changes in product mix or customer concentration. Analysts have issued three "buy" ratings and no "strong buy" or "hold" ratings, reflecting a cautiously optimistic but not enthusiastic outlook.

Hubei Yihua Chemical Industry Co Ltd (000422.SZ) has been formally classified within the Basic Materials economic sector, specifically under the Diversified Chemicals activity. This taxonomic update provides a clearer structural definition of the company’s operational focus, aligning its market positioning with the broader chemical manufacturing landscape. Concurrently, the company’s risk profile has been updated with specific assessments for dilution and liquidity. The dilution risk is now rated as low, indicating a stable share structure with minimal threat of equity erosion. This assessment offers investors greater confidence regarding the preservation of existing shareholder value. In contrast, the liquidity risk has been categorized as medium. This designation suggests that while the company maintains operational stability, there are moderate considerations regarding cash flow or market trading depth that warrant monitoring. The distinction between low dilution and medium liquidity risk highlights a balanced but cautious financial outlook. These updates collectively refine the analytical framework for Hubei Yihua, moving from undefined metrics to specific, actionable risk and sector classifications. The absence of new analyst coverage or index membership changes in the current data underscores that these internal risk and taxonomy adjustments are the primary drivers of recent informational shifts for the stock.

Analysts project 20.4% upside to a mean price target of 17.13, reflecting strong institutional confidence in future performance.

Return on equity of 7.98% is more than double the 3.68% cohort median, demonstrating efficient capital utilization relative to peers.

Revenue grew at an 8.5% CAGR over four years, showing consistent top-line expansion despite recent volatility in net income.

Cash conversion ratio of 3.76 ranks in the top quartile, suggesting strong operational efficiency compared to the 0.95 cohort median.

Free cash flow turned negative at -1.58 billion CNY, raising concerns about liquidity and ability to fund operations without external financing.

Debt-to-equity ratio of 1.45 is substantially higher than the 0.39 cohort median, indicating elevated financial leverage and credit risk.

Revenue ¥25.65B, +1,0% YoY; Operating income −38,6% YoY.

• ▍Revenue ¥25.65B, +1,0% YoY
• ▍Operating income −38,6% YoY
• ▍Net income −24,2% YoY
• ▍Free cash flow +57,2% YoY
• ▍Net margin 3.2%

Revenue ¥25.39B, +49,0% YoY; Operating income +126,0% YoY.

• ▍Revenue ¥25.39B, +49,0% YoY
• ▍Operating income +126,0% YoY
• ▍Net income +135,6% YoY
• ▍Free cash flow −1 626,9% YoY
• ▍Net margin 4.2%

Revenue ¥17.04B, −17,7% YoY; Operating income −67,8% YoY.

• ▍Revenue ¥17.04B, −17,7% YoY
• ▍Operating income −67,8% YoY
• ▍Net income −79,1% YoY
• ▍Free cash flow −117,2% YoY
• ▍Net margin 2.7%

Revenue ¥20.71B, +11,7% YoY; Operating income +33,9% YoY.

• ▍Revenue ¥20.71B, +11,7% YoY
• ▍Operating income +33,9% YoY
• ▍Net income +37,9% YoY
• ▍Free cash flow −25,1% YoY
• ▍Net margin 10.4%

Revenue ¥18.54B; Operating income ¥2.20B.

• ▍Revenue ¥18.54B
• ▍Operating income ¥2.20B
• ▍Net margin 8.5%